• 3806 Citations
  • 22 h-Index
1974 …2018
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Victoria H. Freedman is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 6 Similar Profiles
Thalidomide Medicine & Life Sciences
Mycobacterium tuberculosis Medicine & Life Sciences
Mycobacterium bovis Medicine & Life Sciences
Nude Mice Medicine & Life Sciences
Tumor Necrosis Factor-alpha Medicine & Life Sciences
Tuberculosis Medicine & Life Sciences
Meningeal Tuberculosis Medicine & Life Sciences
Growth Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Publications 1974 2018

  • 3806 Citations
  • 22 h-Index
  • 35 Article

Competency-based assessment for the training of PhD students and early-career scientists

Verderame, M. F., Freedman, V. H., Kozlowski, L. M. & McCormack, W. T., May 31 2018, In : eLife. 7

Research output: Contribution to journalArticle

Open Access
Students
Research

Erratum: Use of IMiD3, a thalidomide analog, as an adjunct to therapy for experimental tuberculous meningitis (Antimicrobial Agents and Chemotherapy (2002) 46:6 (1887-1895))

Tsenova, L., Mangaliso, B., Muller, G., Chen, Y., Freedman, V. H., Stirling, D. & Kaplan, G., 2002, In : Antimicrobial Agents and Chemotherapy. 46, 7, p. 2313 1 p.

Research output: Contribution to journalArticle

Meningeal Tuberculosis
Investigational Therapies
Thalidomide
Anti-Infective Agents
Drug Therapy
80 Citations (Scopus)

Mycobacterial antigens exacerbate disease manifestations in Mycobacterium tuberculosis-infected mice

Moreira, A. L., Tsenova, L., Aman, M. H., Bekker, L. G., Freeman, S., Mangaliso, B., Schröder, U., Jagirdar, J., Rom, W. N., Tovey, M. G., Freedman, V. H. & Kaplan, G., 2002, In : Infection and Immunity. 70, 4, p. 2100-2107 8 p.

Research output: Contribution to journalArticle

Mycobacterium tuberculosis
Mycobacterium bovis
Antigens
Lung
Tumor Necrosis Factor-alpha
44 Citations (Scopus)

Use of IMiD3, a thalidomide analog, as an adjunct to therapy for experimental tuberculous meningitis

Tsenova, L., Mangaliso, B., Muller, G., Chen, Y., Freedman, V. H., Stirling, D. & Kaplan, G., 2002, In : Antimicrobial Agents and Chemotherapy. 46, 6, p. 1887-1895 9 p.

Research output: Contribution to journalArticle

Meningeal Tuberculosis
Investigational Therapies
Thalidomide
Pharmaceutical Preparations
Leukocytosis
405 Citations (Scopus)

Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-α/β

Manca, C., Tsenova, L., Bergtold, A., Freeman, S., Tovey, M., Musser, J. M., Barry, C. E., Freedman, V. H. & Kaplan, G., May 8 2001, In : Proceedings of the National Academy of Sciences of the United States of America. 98, 10, p. 5752-5757 6 p.

Research output: Contribution to journalArticle

Mycobacterium tuberculosis
Virulence
Immunity
Lung
Messenger RNA